The p97 Inhibitor UPCDC-30245 Blocks Endo-Lysosomal Degradation.
The p97 Inhibitor UPCDC-30245 Blocks Endo-Lysosomal Degradation.
复制标题
DOI:
10.3390/ph15020204
复制
发表时间:
2022-02-07
期刊:
影响因子:
--
通讯作者:
Chou TF
中科院分区:
文献类型:
--
作者:
Wang F;Li S;Cheng KW;Rosencrans WM;Chou TF
The diverse modes of action of small molecule inhibitors provide versatile tools to investigate basic biology and develop therapeutics. However, it remains a challenging task to evaluate their exact mechanisms of action. We identified two classes of inhibitors for the p97 ATPase: ATP competitive and allosteric. We showed that the allosteric p97 inhibitor, UPCDC-30245, does not affect two well-known cellular functions of p97, endoplasmic-reticulum-associated protein degradation and the unfolded protein response pathway; instead, it strongly increases the lipidated form of microtubule-associated proteins 1A/1B light chain 3B (LC3-II), suggesting an alteration of autophagic pathways. To evaluate the molecular mechanism, we performed proteomic analysis of UPCDC-30245 treated cells. Our results revealed that UPCDC-30245 blocks endo-lysosomal degradation by inhibiting the formation of early endosome and reducing the acidity of the lysosome, an effect not observed with the potent p97 inhibitor CB-5083. This unique effect allows us to demonstrate UPCDC-30245 exhibits antiviral effects against coronavirus by blocking viral entry.
登录
查看更多内容
影响因子:
3.4
作者:
Fang, Chen-Jie;Gui, Lin;Zhang, Xiaoyi;Moen, Derek R.;Li, Kelin;Frankowski, Kevin J.;Lin, Henry J.;Schoenen, Frank J.;Chou, Tsui-Fen
通讯作者:
Chou, Tsui-Fen
影响因子:
7.6
作者:
Brown, Ariane J.;Won, John J.;Sheahan, Timothy P.
通讯作者:
Sheahan, Timothy P.
DOI:
10.1073/pnas.1416660111
发表时间:
2014-10-14
影响因子:
11.1
作者:
Kan, Shih-hsin;Aoyagi-Scharber, Mika;Neufeld, Elizabeth F.
通讯作者:
Neufeld, Elizabeth F.
影响因子:
4.4
作者:
Gaetani, Massimiliano;Sabatier, Pierre;Zubarev, Roman A.
通讯作者:
Zubarev, Roman A.
影响因子:
4.9
作者:
Keyaerts, Els;Li, Sandra;Maes, Piet
通讯作者:
Maes, Piet